BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/2/2022 6:17:50 AM | Browse: 559 | Download: 1715
 |
Received |
|
2022-06-07 04:48 |
|
Peer-Review Started |
|
2022-06-07 04:51 |
|
First Decision by Editorial Office Director |
|
2022-06-27 21:07 |
|
Return for Revision |
|
2022-06-27 23:36 |
|
Revised |
|
2022-06-29 00:54 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2022-08-11 02:57 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2022-08-12 21:43 |
|
Articles in Press |
|
2022-08-12 21:43 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-08-23 06:50 |
|
Publish the Manuscript Online |
|
2022-09-02 06:17 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Risk stratification of primary liver cancer
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
You-Wen Tan |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Social Development Project of Jiangsu Province |
BE2020775 |
| Chinese Federation of Public Health Foundation |
GWLM202002 |
| Social Development Project of Zhenjiang City |
SH2020032 |
|
| Corresponding Author |
You-Wen Tan, MD, Chief Doctor, Professor, Department of Hepatology, The Third Hospital of Zhenjiang Affiliated Jiangsu University, No. 300 Daijiamen, Runzhou Distinct, Zhenjiang 212000, Jiangsu Province, China. tyw915@sina.com |
| Key Words |
Risk factors; Model; Primary liver cancer; Hepatocellular carcinoma |
| Core Tip |
PLA prediction models with good clinical validation values have been applied clinically, such as the Toronto hepatocellular carcinoma (HCC) risk index (THRI), REACH-B model, and PAGE-B model. Therefore, the Chinese, together with several research societies, have formulated the “Guideline for stratified screening and surveillance of primary liver cancer (2020 edition).” This guideline outlines PLC screening in at-risk populations, both in hospitals and communities. It is recommended to stratify the at-risk population into four risk levels: low-, intermediate-, high-, and extremely high-risk. This is highly recommended and applied in clinical practice. |
| Publish Date |
2022-09-02 06:17 |
| Citation |
Tan YW. Risk stratification of primary liver cancer. World J Clin Cases 2022; 10(26): 9545-9549 |
| URL |
https://www.wjgnet.com/2307-8960/full/v10/i26/9545.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v10.i26.9545 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
